PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq. Electronic address: Hayderm36@yahoo.com.\', \'Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Baghdad, Iraq. Electronic address: Dr.alialgareeb78@yahoo.com.\', \'Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: squsti@kau.edu.sa.\', \'Department of Chemistry, College of Sciences, University of Ha\'il, Ha\'il, Saudi Arabia. Electronic address: eida.alshammari@uoh.edu.sa.\', \'Department of Biochemistry, Faculty of Natural Sciences, Kogi State University, P.M.B. 1008 Anyigba, Nigeria. Electronic address: atanufo@gmail.com.\', \'Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt. Electronic address: dr_gaber_batiha@vetmed.dmu.edu.eg.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(21)00977-X10.1016/j.biopha.2021.112193
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 34543987
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34543987>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34543987>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all